[1]王红琳*,吴正红,陈亚萍.重度子痫前期患者血浆中环状 RNA 差异表达分析[J].中国计划生育和妇产科,2019,(8):57-61.
 WANG Hong-lin*,WU Zheng-hong,CHEN Ya-ping.Analysis of differential expression of circular RNA in plasma of patients with severe preeclapsia[J].Chinese Journal of Family Planning & Gynecotokology,2019,(8):57-61.
点击复制

重度子痫前期患者血浆中环状 RNA 差异表达分析
分享到:

《中国计划生育和妇产科》[ISSN:1674-4020/CN:51-1708/R]

卷:
期数:
2019年8期
页码:
57-61
栏目:
论著与临床
出版日期:
2019-08-25

文章信息/Info

Title:
Analysis of differential expression of circular RNA in plasma of patients with severe preeclapsia
作者:
王红琳*吴正红陈亚萍
复旦大学附属上海市第五人民医院妇产科
Author(s):
WANG Hong-lin*WU Zheng-hongCHEN Ya-ping
Department of Obstetrics and Gynecology, The Fifth People's Hospital of Shanghai,Fudan University, Shanghai 200240, P.R.China
关键词:
妊娠期高血压疾病环状 RNA 早期诊断标志物
Keywords:
gestational hypertensioncircular RNAearly diagnosis markers
分类号:
R 714.2
摘要:
目的分析重度子痫前期患者血浆中环状 RNA 表达特征,为进一步研究差异表达的环状 RNA 并筛选重度子痫前期患者早期诊断标志物打下基础。方法选取2016年6月至2018年6月在上海市第五人民医院妇产科分娩的重度子痫前期孕妇40例为观察组,40例正常孕妇为对照组,每个研究对象抽取10 mL全血并制备血浆。随机选取5例重度子痫前期患者及正常孕妇的样本,采用Trizol法提取总RNA。将标记的环状 RNA 与Arraystar Human 环状 RNA芯片杂交。对所获得的数据进行分析,筛选出观察组与对照组之间存
Abstract:
ObjectiveTo analyze the expression of circular RNA in plasma of patients with severe preeclapsia (SPE), and to lay the foundation for further study of differentially expressed circular RNA and screening for early diagnosis markers of SPE patients. Methods

参考文献/References:

[1]Henderson J T,Thompson J H, Burda B U,et al. Preeclampsia screening [J].JAMA,2017,317(16):1668-1685. [2]Schiff E, Friedman S A,Sibai B M.Conservative management of severe preeclampsia remote from term[J].American Jourral of Obsterics & Gynecology,2013,209(5):425. [3]ADANE A A, MISHRA G D, TOOTH L R. Adult Pre-pregnancy Weight Change and Risk of Developing Hypertensive Disorders in Pregnancy [J]. Paediatric and Perinatal Epidemiology, 2017, 31 (3): 167-175. [4]LIU Jia, LIU Jia-mei, SHI Lin-ying, et al. Preliminary study of microRNA-126 as a novel therapeutic target for primary hypertension [J]. International Journal of Molecular Medicine, 2018, 41 (4): 1835-1844. [5]DENG L, BRADSHAW A C, BAKER A H. Role of noncoding RNA in vascular remodeling [J]. Current Opinion in Lipidology, 2016, 27 (5): 439. [6]PANCHAPAKESAN U, POLLOCK C. Long non-coding RNAs - towards precision medicine in diabetic kidney disease? [J]. Clinical Science, 2016, 130 (18): 1599-1602. [7]MEMCZAK S, JENS M, ELEFSINIOTI A, et al. Circular RNAs are a large class of animal RNAs with regulatory potency [J]. Nature, 2013, 495 (7441): 333-338. [8]HSIAO K Y, SUN H-s, TSAI S J. Circular RNA–new member of noncoding RNA with novel functions [J]. Experimental Biology and Medicine, 2017, 242 (11): 1136. [9]MEMCZAK S, PAPAVASILEIOU P, PETERS O A. Identification and characterization of circular RNAs as a new class of putative biomarkers in human blood [J]. PLOS One, 2015, 10 (10): e0141214. [10]Tan L, Yu JT, Hu N, et al. Non-coding RNAs in Alzheimer's disease [J]. Mol Neurobiol, 2013, 47 (1):382-393. [11]BURD C E, JECK W R, LIU Yan, et al. Expression of linear and novel circular forms of an INK4/ARF-associated non-coding RNA correlates with atherosclerosis risk[J]. PLOS Genetics, 2010, 6(12): e1001233. [12]XIA Tian, LIAO Qi, JIANG Xiao-ming, et al. Long noncoding RNA associated-competing endogenous RNAs in gastric cancer [J]. Scientific Reports, 2014, 4: 6088. [13]HANSEN T B, JENSEN T I, CLAUSEN B H, et al. Natural RNA circles function as efcient microRNA sponges [J]. Nature, 2013, 495(7441): 384–388. [14]HANSEN T B, KJEMS J, DAMGAARD C K. Circular RNA and miR-7 in cancer [J]. Cancer Research, 2013, 73(18): 5609-5612. [15]DACHEW B A, MAMUN A, MARAVILLA J C, et al. Association between hypertensive disorders of pregnancy and the development of offspring mental and behavioural problems: A systematic review and meta-analysis [J]. Psychiatry Research, 2018, 260 (2): 458-467. [16]HOFMEYR G J, ATALLAH A N, DULEY L. Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems [J]. Cochrane Database of Systematic Reviews, 2006, 1 (3): CD001059. [17]LUITJES S H, WOUTERS M G, KONIG T, et al. Hypertensive disorders in pregnancy: a review of international guidelines [J]. Hypertension in Pregnancy, 2013, 32 (4): 367-377. [18]CAIRNS A E, TUCKER K L, LEESON P A, et al. Survey of healthcare professionals regarding adjustment of antihypertensive medication(s) in the postnatal period in women with hypertensive disorders of pregnancy [J]. Pregnancy Hypertension: an International Journal of Women's Cardiovascular Health, 2016, 6 (4): 256-258. [19]SALZMAN J, GAWAD C, WANG P L, et al. Circular RNAs are the predominant transcript isoform from hundreds of human genes in diverse cell types [J]. PLOS One, 2012, 7 (2): e30733. [20]LI Yan, ZHENG Qiu-peng, BAO Chun-yang, et al. Circular RNA is enriched and stable in exosomes: a promising biomarker for cancer diagnosis [J]. Cell Research, 2015, 25 (8): 981-984. [21]RYBAK-WOLF A, STOTTMEISTER C, GLAZAR P, et al. Circular RNAs in the mammalian brain are highly abundant, conserved, and dynamically expressed [J]. Molecular Cell, 2015, 58 (5): 870-885. [22]HOFFMANN S, OTTO C, DOOSE G, et al. A multi-split mapping algorithm for circular RNA, splicing, trans-splicing and fusion detection [J]. Genome Biology, 2014, 15 (2): R34. [23]CONN S J, PILLMAN K A, TOUBIA J, et al. The RNA binding protein quaking regulates formation of circRNAs [J]. Cell, 2015, 160 (6): 1125-1134. [24]MEMCZAK S, JENS M, ELEFSINIOTI A, et al. Circular RNAs are a large class of animal RNAs with regulatory potency [J]. Nature, 2013, 495 (7441): 333-338.

相似文献/References:

[1]黄辉秀,谭毅.妊娠期高血压疾病预测和预防的研究现状[J].中国计划生育和妇产科,2009,(05):0.
 HUANG Hui-xiu,TAN Yi MCH Hospital of Fangcheng urban district,Fangchenggang city Guangxi automous region 80,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2009,(8):0.
[2]张珺,仲红丽.妊娠期高血压疾病监测系统预测及早期干预520例临床分析[J].中国计划生育和妇产科,2009,(06):0.
[3]肖兵,高岩,熊庆,等.妊娠期高血压疾病的流行病学研究进展[J].中国计划生育和妇产科,2010,(01):0.
[4]何怡,赵可文,唐莉,等.卡孕栓防治妊娠期高血压疾病产后出血的疗效观察[J].中国计划生育和妇产科,2010,(02):0.
 HE Yi,ZHAO Ke-wen,TANG LiMCH hospital of Dongguan city,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2010,(8):0.
[5]庞春蓉,傅晓冬.肾上腺髓质素与妊娠期高血压疾病[J].中国计划生育和妇产科,2010,(02):0.
[6]陈倩,段成城,傅晓冬,等.血清T辅助细胞比率与妊娠期高血压疾病的关系和意义[J].中国计划生育和妇产科,2010,(03):0.
 CHEN Qian,DUAN Cheng-cheng,FU Xiao-dong..[J].Chinese Journal of Family Planning & Gynecotokology,2010,(8):0.
[7]陈茜松,刘丽俊,季淑英,等.妊娠期高血压疾病患者血清抵抗素水平的变化及其临床意义[J].中国计划生育和妇产科,2011,(03):0.
 CHEN Qian-song,LIU Li-jun,JI Shu-ying.[J].Chinese Journal of Family Planning & Gynecotokology,2011,(8):0.
[8]侯卫萍,程兰,黄立,等.血清胱抑素C在妊娠期高血压疾病中的应用[J].中国计划生育和妇产科,2011,(06):0.
 HOU Wei-ping,CHENG Lan,HUANG Li.[J].Chinese Journal of Family Planning & Gynecotokology,2011,(8):0.
[9]刘圣英,杨建恩.孕期补钙预防高危孕妇妊娠期高血压疾病的临床观察[J].中国计划生育和妇产科,2012,(03):0.
 LIU Sheng-ying,YANG Jian-en.[J].Chinese Journal of Family Planning & Gynecotokology,2012,(8):0.
[10]金爽,尹春艳.IGF-Ⅰ、IGF-Ⅱ、IGFBP-1与妊娠期高血压疾病的相关性研究[J].中国计划生育和妇产科,2012,(05):0.
 JIN Shuang,YIN Chun-yan University of South China Teaching Hospital,the Second Peoples Hospital in Guangdong Province,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2012,(8):0.

备注/Memo

备注/Memo:
上海市闵行区自然科学基金(项目编号:2016MHZ23);上海市闵行区医学特色专科(项目)建设(项目编号:2017MWTZ05)
更新日期/Last Update: 2019-08-25